证券代码：002108 证券简称：沧州明珠 公告编号：2026-008 沧州明珠塑料股份有限公司 关于召开 2026 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2026 年第二次临时股东会 1 （2）公司董事、高级管理人员。 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市 公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有 关规定。 4、会议时间： （1）现场会议时间：2026 年 03 月 02 日 14:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2026 年 03 月 02 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易 所互联网投票系统投票的具体时间为 2026 年 03 月 02 日 9:15 至 15:00 的任意时 间。 5、会议的召开方式：现场表决与网络投票相结合 ...

证券代码：002108 证券简称：沧州明珠 公告编号：2026-006 沧州明珠塑料股份有限公司 第九届董事会第八次（临时）会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 沧州明珠塑料股份有限公司（以下简称"公司"）第九届董事会第八次（临 时）会议于 2026 年 02 月 09 日以专人送达或电子邮件的方式发出会议通知和会 议议案，现场会议于 2026 年 02 月 12 日上午 10:00 在公司六楼会议室召开，通 讯表决截止时间为 2026 年 02 月 12 日上午 12:00。会议应出席董事九名，实际 出席董事九名，其中，现场投票表决董事五名，通讯表决董事四名，采用通讯表 决的董事分别是潘立雪女士、魏若奇先生、冯颖女士和梅丹女士。会议由公司董 事长于增胜先生主持，会议的召集、召开符合《公司法》和《公司章程》的规定， 合法有效。 本次会议采取现场投票结合通讯表决的方式，审议通过了以下议案： 一、《关于补选非独立董事的议案》； 该议案已经公司第九届董事会提名委员会 2026 年第一次会议审议通过。 根据控制权转让事项后续安排，公司部分董事提 ...

沧州明珠2月12日公告，公司董事会近日收到董事长、总经理于增胜的书面辞职报告，因公司控制权转 让的后续安排，于增胜辞去公司第九届董事会董事长、董事职务，同时一并辞去提名委员会委员、战略 委员会委员及主任委员职务，辞职后继续在公司担任总经理职务。 ...

证券代码：002108 证券简称：沧州明珠 公告编号：2026-005 沧州明珠塑料股份有限公司 关于股东股份全部解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 沧州明珠塑料股份有限公司（以下简称"本公司"）2026年02月12日接到公 司股东河北沧州东塑集团股份有限公司（以下简称"东塑集团"）函告，获悉东 塑集团所持有的本公司股份全部解除质押，具体事项如下： 一、股东股份解除质押的基本情况 2、解除质押后股东股份累计质押情况 截至本公告披露日，东塑集团及其一致行动人所持公司股份质押情况如下： | | | | | | | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | 情况 | | 情况 | | | 股东名称 | 持股数量 | 持股 | 本次解除质 押前质押股 | 本次解除质 押后质押股 | 占其所持 | | 占公司 总股本 | 已质押股份 | 占已 | 未质押股 ...

Core Viewpoint - Guangzhou Light Industry has successfully acquired the voting rights of 19.78% of Cangzhou Mingzhu, becoming the new controlling shareholder, which will help extend its business into the plastic industry chain and achieve synergy with its main business [2][4]. Group 1: Acquisition Details - The acquisition involved two steps: first, Guangzhou Light Industry purchased 1.67 billion shares of Cangzhou Mingzhu from Dongsu Group for 710 million yuan, and then obtained the corresponding voting rights through a voting rights entrustment [9]. - Cangzhou Mingzhu specializes in polyethylene pipelines, BOPA films, and lithium-ion battery separators, with a market value exceeding 8 billion yuan and a revenue of 2.078 billion yuan in the first nine months of 2025 [11]. Group 2: Strategic Goals - The management team, led by Chairman Lin Hu, aims to "recreate a new light industry" and has initiated three acquisitions in the past year to achieve external growth through capital operations [5][14]. - The company has set a target to optimize resource allocation and increase effective investments, focusing on driving external growth through capital empowerment [15]. Group 3: Business Expansion - Guangzhou Light Industry has a rich portfolio in consumer goods, with annual revenue of approximately 25 billion yuan, and has been actively expanding its business into various sectors, including food and beverage, smart home appliances, and new energy [3][28]. - The company has successfully launched several high-revenue products in the past year, with its food and beverage sector seeing revenue and profit growth exceeding 24% [31]. Group 4: Recent Challenges - The failed acquisition of the snack brand, Good Products, due to a last-minute change by the controlling shareholder, has led Guangzhou Light Industry to seek compensation of over 20 million yuan [6][24]. - Despite this setback, the company remains confident in its capital market strategies and continues to pursue growth opportunities [27].

证券代码：002108 证券简称：沧州明珠 公告编号：2026-004 沧州明珠塑料股份有限公司 关于股东股份部分解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 登录新浪财经APP 搜索【信披】查看更多考评等级 2、解除质押后股东股份累计质押情况 截至本公告披露日，东塑集团及其一致行动人所持公司股份质押情况如下： ■ 二、其他说明 沧州明珠塑料股份有限公司（以下简称"本公司"）2026年2月10日接到前控股股东河北沧州东塑集团股 份有限公司（以下简称"东塑集团"）函告，获悉东塑集团所持有的本公司股份部分解除质押，具体事项 如下： 一、股东股份解除质押的基本情况 1、本次股份解除质押基本情况 ■ 在解除质押期间，东塑集团于2026年2月6日通过协议转让出让其持有的166,539,465股股份，持股数量变 为147,373,438股，占公司总股本比例为8.94%，转让完成后东塑集团不再属于公司控股股东，仍属于持 股5%以上的股东。 ■ 截至本公告披露日，东塑集团所质押的股份不存在平仓风险，也不会对公司的生产经营、公司治理等产 生影响。公司将持续关注 ...

（文章来源：证券日报） 证券日报网讯 2月10日，沧州明珠发布公告称，公司2026年2月10日接到前控股股东河北沧州东塑集团 股份有限公司（以下简称"东塑集团"）函告，获悉东塑集团所持有的本公司股份部分解除质押，本次解 除质押股份数量94，626，562股。 ...

沧州明珠公告称，2026年2月10日接到前控股股东东塑集团函告，其部分股份解除质押。2月6日，东塑 集团解除质押94,626,562股，占其所持股份比例30.14%，当日通过协议转让出让166,539,465股，不再为 控股股东。2月9日，又解除质押43,373,438股，占比29.43%。截至公告披露日，东塑集团及其一致行动 人累计质押104,000,000股，占其所持股份65.16%。所质押股份无平仓风险，不影响公司经营。 ...

关于股东股份部分解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 沧州明珠塑料股份有限公司（以下简称"本公司"）2026年2月10日接到前控 股股东河北沧州东塑集团股份有限公司（以下简称"东塑集团"）函告，获悉东 塑集团所持有的本公司股份部分解除质押，具体事项如下： 一、股东股份解除质押的基本情况 证券代码：002108 证券简称：沧州明珠 公告编号：2026-004 沧州明珠塑料股份有限公司 截至本公告披露日，东塑集团及其一致行动人所持公司股份质押情况如下： | 股东名称 | 是否为控股股东 或第一大股东及 | 本次解除质 押股份数量 | 占其所 持股份 | 占公司 总股本 | 起始日 | 解除日期 | 解除质押 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 其一致行动人 | （股） | 比例 | 比例 | | | 原因 | | | 东塑集团 | 是 | 91，200,000 | 29.05% | 5.53% | 2025 年 1 月 22 日 | 202 ...

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]